文献速递炎症性肠病

黑种人溃疡性结肠炎患者接受先进治疗较少且结局更差

Black Race is Associated with Decreased Exposure to Advanced Therapies and Worse Outcomes in Individuals with Ulcerative Colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2024-11-30

基于TriNetX数据库的回顾性分析显示,与匹配的白种人相比,黑种人溃疡性结肠炎患者在诊断后6个月和10年时死亡率更高、接受溃疡性结肠炎特异性治疗更少、急诊就诊和住院率更高,且6个月时阿片类药物处方更多;亚裔患者未呈现相同趋势。

要点

  • 黑种人溃疡性结肠炎患者6个月和10年死亡率均高于白种人(2.7% vs. 1.9%和8.1% vs. 6.9%,p<0.0001)。
  • 黑种人接受溃疡性结肠炎特异性治疗的比例低于白种人(6个月21.3% vs. 26.4%,10年30% vs. 36%,p<0.0001)。
  • 黑种人6个月阿片类药物处方率高于白种人(18.5% vs. 15.7%,p<0.0001),亚裔患者未呈现相同趋势。

核心结论

  • 黑种人溃疡性结肠炎患者比白种人接受更少的疾病特异性治疗,住院和死亡率更高,阿片类药物处方率更高;亚裔患者未见这些趋势,揭示黑种人溃疡性结肠炎诊疗存在差异,有机会进行针对性干预。

研究设计与样本

  • 基于TriNetX数据库的两项基于人群的回顾性分析,黑种人溃疡性结肠炎患者n=22,519,亚裔n=8,626,按年龄、性别和族裔匹配。

主要发现

  • 诊断后6个月和10年,黑种人死亡率高于白种人(2.7% vs. 1.9%和8.1% vs. 6.9%,p<0.0001)。
  • 黑种人接受溃疡性结肠炎特异性治疗少于白种人(6个月21.3% vs. 26.4%,10年30% vs. 36%,p<0.0001)。
  • 黑种人急诊就诊率高于白种人(6个月22.3% vs. 13.6%,10年41.2% vs. 31.5%,p<0.0001),住院率也更高(6个月30.1% vs. 25.8%,10年42.6% vs. 39.9%,p<0.0001)。
  • 黑种人6个月阿片类药物处方率高于白种人(18.5% vs. 15.7%,p<0.0001)。
  • 亚裔10年死亡率低于白种人(5.6% vs. 7.7%,p<0.0001),6个月溃疡性结肠炎特异性用药率高于白种人(28.6% vs. 26.5%,p=0.002),住院率更高(6个月38.8% vs. 27.7%,10年50% vs. 42.2%,p<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For people diagnosed with ulcerative colitis (UC), racial disparities exist both in access to medications and clinical outcomes. METHODS: We used the TriNetX database for two population-based retrospective analyses with Black (n = 22,519) and Asian (n = 8,626) individuals with UC matched for age, sex, and ethnicity. Outcomes included mortality, medication prescriptions, and clinical encounters at 6 months and 10 years. RESULTS: At 6 months and 10 years after diagnosis, Black people had increased mortality (2.7% vs. 1.9% and 8.1% vs. 6.9%, p < 0.0001), were prescribed fewer UC-specific therapies (21.3% vs. 26.4% and 30% vs. 36%, p < 0.0001), had higher rates of emergency department visits (22.3% vs. 13.6% and 41.2% vs. 31.5%, p < 0.0001), and higher hospitalisation rates (30.1% vs. 25.8% and 42.6% vs. 39.9%, p < 0.0001). At 6 months, they had more opioid prescriptions (18.5% vs. 15.7%, p < 0.0001). Asian people had lower mortality at 10 years (5.6% vs. 7.7%, p < 0.0001), higher rates of UC-specific medications at 6 months (28.6% vs. 26.5%, p = 0.002), and more hospitalizations (38.8% vs. 27.7%, p < 0.0001 at 6 months and 50% vs. 42.2%, p < 0.0001 at 10 years). CONCLUSION: Black individuals with UC are prescribed fewer disease-specific therapies compared to White individuals and have increased hospitalizations and mortality. Black individuals have higher rates of opioid prescriptions. Opioids have been associated with increased complication rates in inflammatory bowel disease. These trends are not seen in Asian individuals. This reveals critical disparities in the care of Black people with UC with opportunity for targeted interventions.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. McFalls C, Chaaban L, Melia J, et al. Black Race is Associated with Decreased Exposure to Advanced Therapies and Worse Outcomes in Individuals with Ulcerative Colitis. Aliment Pharmacol Ther. 2024. PMID: 39614981. doi:10.1111/apt.18405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。